Conclusion of a non-exclusive discount contract pursuant to Section 130a (8) SGB V for medicinal products with the active ingredient fusidic acid (ATC code: D06AX01) within the period from August 1, 2020 to July 31, 2022 with the option of concluding the contract at any time during the term ("open house model ").

The contractual partners can be viewed at: https://www.aok-gesundheitpartner.de/nds/arzneimittel/rabatt/index_03504.html?bl=nds

For the active ingredient fusidic acid (ATC code: D06AX01), AOK - The Health Insurance Fund for Lower Saxony offers discount contracts to all interested pharmaceutical companies for the period until the entry into force of exclusive contracts as a result of a formal award procedure in accordance with the regulations of Part 4 of the GWB, without a selection decision at. The contracts are concluded as part of an "open house model" and act as a bridge between the start of generic competition (patent expiry) and the awarding of exclusive contracts. The contracts offered are not exclusive; Contracts with all market participants (pharmaceutical companies) are requested by AOK Lower Saxony. In the open house model, uniform conditions apply to all participants. Contract contents, conditions and access procedures are uniform - individual negotiations are generally not conducted. The contract runs for a maximum of twenty-four months, the earliest contract start is August 1, 2020. All contracts end on July 31, 2022 at the latest, regardless of the date of the respective contract. An entry or a contract can be made within the 24 month period on the first of each month. There is a right of termination six weeks at the end of each month. AOK - The health insurance fund for Lower Saxony reserves the right to replace the non-exclusive open-house discount contracts with exclusive discount contracts during the term of the contract. With the entry into force of exclusive discount contracts, the open house contracts are terminated in accordance with the contractual regulation, ie the open house contracts end automatically. According to the experience of the AOK Lower Saxony, exclusive discount contracts generally come into force six to eight months after the publication of the relevant announcement in the supplement to the Official Journal of the European Union. The future contractors in the open house model are asked to inform themselves regularly about these announcements in the supplement to the Official Journal of the European Union.

Interested pharmaceutical companies can request the contractual documents and the contractual terms and conditions at the contact address given under I.1).

Contracts for the active ingredient fusidic acid (ATC code: D06AX01) will be concluded for the first time with effect from August 1, 2020. Interested parties who would like to become a contract partner on this date must submit the contract documents to be submitted by June 27, 2020 to the address specified in the contract documents. It depends on the access at the AOK Lower Saxony. Later contracts can be concluded for the first of a month during the 24-month maximum term. Organizationally, a lead time of generally 35 calendar days on the part of the AOK is necessary to complete the necessary work, e.g. B. to be able to guarantee the contract registration in the Lauer-Taxe®. The exact entry deadlines will be announced with the contract documents. This publication is not a public contract within the meaning of Directive (2014/24 / EU) or public procurement law. In order to ensure the greatest possible degree of transparency for the intended contracts, the publication is published in the supplement to the Official Journal of the European Union. In the absence of a corresponding publication form, the contract notice will be used. The resulting conceptual requirements, such as the process name "open process", are solely due to the use of this notice form and the publication platform. This is not associated with any further significance, in particular the submission of subcontracting regulations, unless they are legally binding.